ASSEMBLY BIOSCIENCES, INC. (ASMB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ASSEMBLY BIOSCIENCES, INC. reported revenue of $72.30M, up 153.5% from the prior year. The company ran a net loss, with a net margin of -8.5%. It held $257.59M in total assets against $50.84M in total liabilities.
Key ratios (FY2025)
-16.8%
Operating margin
-8.5%
Net margin
-3.0%
Return on equity
+153.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.30M | $28.52M | — | — | — | — | — | — | — | — |
| Operating Income | -$12.12M | -$45.42M | -$64.65M | -$94.11M | -$132.69M | -$64.78M | -$102.71M | -$92.73M | -$52.23M | -$45.28M |
| Net Income | -$6.12M | -$40.18M | -$61.23M | -$93.09M | -$129.85M | -$62.15M | -$97.63M | -$90.75M | -$42.81M | -$44.26M |
| EPS (Diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | — | — | — | — | — |
| Total Assets | $257.59M | $119.17M | $136.82M | $101.79M | $191.06M | $283.25M | $339.91M | $268.05M | $169.30M | $98.12M |
| Total Liabilities | $50.84M | $85.81M | $95.73M | $19.13M | $22.13M | $42.68M | $66.69M | $57.39M | $56.18M | $18.24M |
| Shareholders' Equity | $206.75M | $33.36M | $41.10M | $82.66M | $168.93M | $240.58M | $273.22M | $210.65M | $113.12M | $79.88M |
| Cash & Equivalents | $58.45M | $38.34M | $19.84M | $52.42M | $45.63M | $59.44M | $46.73M | $41.47M | $82.03M | $28.57M |
| Operating Cash Flow | -$41.09M | -$51.12M | $22.74M | -$84.46M | -$93.40M | -$62.96M | -$84.07M | -$64.96M | $1.86M | -$34.88M |
| Capital Expenditures | $66.0K | $28.0K | $255.0K | $102.0K | $3.10M | $470.0K | $1.55M | $340.0K | $865.0K | $147.0K |
| Shares Outstanding | 15.86M | 7.46M | 5.48M | 4.07M | 48.12M | 34.03M | 32.56M | 25.50M | 20.14M | 17.25M |